US 7534900
Process for the purification of duloxetine hydrochloride
granted A61KA61K31/38A61P
Quick answer
US patent 7534900 (Process for the purification of duloxetine hydrochloride) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/38, A61P, A61P13/00, A61P25/24